Glycolipid Synthesis in Normal and Virus-Transformed Hamster Cell
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Sphingolipid Metabolism Diseases ⁎ Thomas Kolter, Konrad Sandhoff
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1758 (2006) 2057–2079 www.elsevier.com/locate/bbamem Review Sphingolipid metabolism diseases ⁎ Thomas Kolter, Konrad Sandhoff Kekulé-Institut für Organische Chemie und Biochemie der Universität, Gerhard-Domagk-Str. 1, D-53121 Bonn, Germany Received 23 December 2005; received in revised form 26 April 2006; accepted 23 May 2006 Available online 14 June 2006 Abstract Human diseases caused by alterations in the metabolism of sphingolipids or glycosphingolipids are mainly disorders of the degradation of these compounds. The sphingolipidoses are a group of monogenic inherited diseases caused by defects in the system of lysosomal sphingolipid degradation, with subsequent accumulation of non-degradable storage material in one or more organs. Most sphingolipidoses are associated with high mortality. Both, the ratio of substrate influx into the lysosomes and the reduced degradative capacity can be addressed by therapeutic approaches. In addition to symptomatic treatments, the current strategies for restoration of the reduced substrate degradation within the lysosome are enzyme replacement therapy (ERT), cell-mediated therapy (CMT) including bone marrow transplantation (BMT) and cell-mediated “cross correction”, gene therapy, and enzyme-enhancement therapy with chemical chaperones. The reduction of substrate influx into the lysosomes can be achieved by substrate reduction therapy. Patients suffering from the attenuated form (type 1) of Gaucher disease and from Fabry disease have been successfully treated with ERT. © 2006 Elsevier B.V. All rights reserved. Keywords: Ceramide; Lysosomal storage disease; Saposin; Sphingolipidose Contents 1. Sphingolipid structure, function and biosynthesis ..........................................2058 1.1. -
A Mouse B16 Melanoma Mutant Deficient in Glycolipids
Proc. Natl. Acad. Sci. USA Vol. 91, pp. 2703-2707, March 1994 Biochemistry A mouse B16 melanoma mutant deficient in glycolipids (glucosyltransferase/glucosylceramide/glucocerebroside) SHINICHI ICHIKAWA*t, NOBUSHIGE NAKAJO*, HISAKO SAKIYAMAt, AND YOSHIo HIRABAYASHI* *Laboratory for Glyco Cell Biology, Frontier Research Program, The Institute of Chemical and Physical Research (RIKEN), 2-1 Hirosawa, Wako-shi, Saitama 351-01, Japan; and *Division of Physiology and Pathology, National Institute of Radiological Sciences, 4-9-1 Anagawa, Chiba-shi, Chiba 260, Japan Communicated by Saul Roseman, December 21, 1993 ABSTRACT Mouse B16 melanoma cell line, GM-95 (for- cosyltransferase would provide an ideal tool. Although sev- merly designated as MEC-4), deficient in sialyllactosylceram- eral glycosylation mutant cells have been isolated by treat- ide was examined for its primary defect. Glycolipids from the ment with a mutagen followed by selection with lectins, mutant cells were analyzed by high-performance TLC. No defects in these mutants were involved in either glycoprotein glycolipid was detected in GM-95 cells, even when total lipid syntheses (for review, see ref. 3), nucleotide sugar syntheses, from 107 cells was analyzed. In contrast, the content of or nucleotide sugar transporters (4). Mutants defective in ceramide, a precursor lipid molecule of glycolipids, was nor- glycolipid-specific transferases have rarely been found. Re- mal. Thus, the deficiency of glycolipids was attributed to the cently, Tsuruoka et al. (5) isolated a mouse mammary car- first glucosylation step of ceramide. The ceramide glucosyl- cinoma mutant that gained GM3 expression by selection with transferase (EC 2.4.1.80) activity was not detected in GM-95 antilactosylceramide (anti-LacCer) monoclonal antibody cells. -
Regulation of Glycolipid Synthesis in HL-60 Cells by Antisense
Proc. Natl. Acad. Sci. USA Vol. 92, pp. 8670-8674, September 1995 Neurobiology Regulation of glycolipid synthesis in HL-60 cells by antisense oligodeoxynucleotides to glycosyltransferase sequences: Effect on cellular differentiation (gangliosides/gene expression/cell maturation) GuicHAo ZENG, TOSHlo ARIGA, XIN-BIN Gu, AND ROBERT K. Yu* Department of Biochemistry and Molecular Biophysics, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298-0614 Communicated by Saul Roseman, Johns Hopkins University, Baltimore, MD, June 8, 1995 ABSTRACT Treatment of the human promyelocytic leuke- Gal1-Gic-Cer mia cell line HL-60 with antisense oligodeoxynucleotides to UDP-N-acetylgalactosamine: 3-1,4-N-acetylgalactosaminyl- transferase (GM2-synthase; EC 2.4.1.92) and CMP-sialic acid:a- GGM3 synd8s EC 2.4.99.8) sequences ef- 2,8-sialyltransferase (GD3-synthase; Gal-Glc-Cer GD3 synthase Grl-Glc-Cer fectively down-regulated the synthesis of more complex ganglio- SA - SA sides in the ganglioside synthetic pathways after GM3, resulting cm sA aon in a remarkable increase in endogenous GM3 with concomitant decreases in more complex gangliosides. The treated cells un- GM2 synthase derwent monocytic differentiation as judged by morphological clwiges, adherent ability, and nitroblue tetrazolium staining. GaiNAc-Gal-Glc-Cer GaINAc-Gal-Glc-Cer SA These data provide evidence that the increased endogenous sk Q ganglioside GM3 may play an important role in regulating IGM2 SA cellular differentiation and that the antisense DNA technique proves to be a powerful tool in manipulating glycolipid synthesis GalGaNAc-Ca-Glc-Cer Gal-GaINAc-Gal-Glc-Cer in the cell. SA SA SA GDlb The composition of gangliosides-in cells undergoes dramatic changes during cellular growth, differentiation, and oncogenic transformation, suggesting a specific role of gangliosides in the Gal-GaINAc-Gal-Gic-Cer Gal-GaINAc-Gal-Glc-Cer regulation of these cellular events (3-5). -
Structural Evidence for Adaptive Ligand Binding of Glycolipid Transfer Protein
doi:10.1016/j.jmb.2005.10.031 J. Mol. Biol. (2006) 355, 224–236 Structural Evidence for Adaptive Ligand Binding of Glycolipid Transfer Protein Tomi T. Airenne†, Heidi Kidron†, Yvonne Nymalm, Matts Nylund Gun West, Peter Mattjus and Tiina A. Salminen* Department of Biochemistry Glycolipids participate in many important cellular processes and they are and Pharmacy, A˚ bo Akademi bound and transferred with high specificity by glycolipid transfer protein University, Tykisto¨katu 6A (GLTP). We have solved three different X-ray structures of bovine GLTP at FIN-20520 Turku, Finland 1.4 A˚ , 1.6 A˚ and 1.8 A˚ resolution, all with a bound fatty acid or glycolipid. The 1.4 A˚ structure resembles the recently characterized apo-form of the human GLTP but the other two structures represent an intermediate conformation of the apo-GLTPs and the human lactosylceramide-bound GLTP structure. These novel structures give insight into the mechanism of lipid binding and how GLTP may conformationally adapt to different lipids. Furthermore, based on the structural comparison of the GLTP structures and the three-dimensional models of the related Podospora anserina HET-C2 and Arabidopsis thaliana accelerated cell death protein, ACD11, we give structural explanations for their specific lipid binding properties. q 2005 Elsevier Ltd. All rights reserved. Keywords: crystal structure; homology modeling; conformational change; *Corresponding author cavity; fluorescence Introduction to the diverse roles of glycolipids in the cell, GLTP could potentially function as a modulator -
Sphingolipids and Cell Signaling: Relationship Between Health and Disease in the Central Nervous System
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 6 April 2021 doi:10.20944/preprints202104.0161.v1 Review Sphingolipids and cell signaling: Relationship between health and disease in the central nervous system Andrés Felipe Leal1, Diego A. Suarez1,2, Olga Yaneth Echeverri-Peña1, Sonia Luz Albarracín3, Carlos Javier Alméciga-Díaz1*, Angela Johana Espejo-Mojica1* 1 Institute for the Study of Inborn Errors of Metabolism, Faculty of Science, Pontificia Universidad Javeriana, Bogotá D.C., 110231, Colombia; [email protected] (A.F.L.), [email protected] (D.A.S.), [email protected] (O.Y.E.P.) 2 Faculty of Medicine, Universidad Nacional de Colombia, Bogotá D.C., Colombia; [email protected] (D.A.S.) 3 Nutrition and Biochemistry Department, Faculty of Science, Pontificia Universidad Javeriana, Bogotá D.C., Colombia; [email protected] (S.L.A.) * Correspondence: [email protected]; Tel.: +57-1-3208320 (Ext 4140) (C.J.A-D.). [email protected]; Tel.: +57-1-3208320 (Ext 4099) (A.J.E.M.) Abstract Sphingolipids are lipids derived from an 18-carbons unsaturated amino alcohol, the sphingosine. Ceramide, sphingomyelins, sphingosine-1-phosphates, gangliosides and globosides, are part of this group of lipids that participate in important cellular roles such as structural part of plasmatic and organelle membranes maintaining their function and integrity, cell signaling response, cell growth, cell cycle, cell death, inflammation, cell migration and differentiation, autophagy, angiogenesis, immune system. The metabolism of these lipids involves a broad and complex network of reactions that convert one lipid into others through different specialized enzymes. Impairment of sphingolipids metabolism has been associated with several disorders, from several lysosomal storage diseases, known as sphingolipidoses, to polygenic diseases such as diabetes and Parkinson and Alzheimer diseases. -
GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies
International Journal of Molecular Sciences Review GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies Andrés Felipe Leal 1 , Eliana Benincore-Flórez 1, Daniela Solano-Galarza 1, Rafael Guillermo Garzón Jaramillo 1 , Olga Yaneth Echeverri-Peña 1, Diego A. Suarez 1,2, Carlos Javier Alméciga-Díaz 1,* and Angela Johana Espejo-Mojica 1,* 1 Institute for the Study of Inborn Errors of Metabolism, Faculty of Science, Pontificia Universidad Javeriana, Bogotá 110231, Colombia; [email protected] (A.F.L.); [email protected] (E.B.-F.); [email protected] (D.S.-G.); [email protected] (R.G.G.J.); [email protected] (O.Y.E.-P.); [email protected] (D.A.S.) 2 Faculty of Medicine, Universidad Nacional de Colombia, Bogotá 110231, Colombia * Correspondence: [email protected] (C.J.A.-D.); [email protected] (A.J.E.-M.); Tel.: +57-1-3208320 (ext. 4140) (C.J.A.-D.); +57-1-3208320 (ext. 4099) (A.J.E.-M.) Received: 6 July 2020; Accepted: 7 August 2020; Published: 27 August 2020 Abstract: GM2 gangliosidoses are a group of pathologies characterized by GM2 ganglioside accumulation into the lysosome due to mutations on the genes encoding for the β-hexosaminidases subunits or the GM2 activator protein. Three GM2 gangliosidoses have been described: Tay–Sachs disease, Sandhoff disease, and the AB variant. Central nervous system dysfunction is the main characteristic of GM2 gangliosidoses patients that include neurodevelopment alterations, neuroinflammation, and neuronal apoptosis. Currently, there is not approved therapy for GM2 gangliosidoses, but different therapeutic strategies have been studied including hematopoietic stem cell transplantation, enzyme replacement therapy, substrate reduction therapy, pharmacological chaperones, and gene therapy. -
Review Sialic Acid-Specific Lectins: Occurrence, Specificity and Function
Cell. Mol. Life Sci. 63 (2006) 1331–1354 1420-682X/06/121331-24 DOI 10.1007/s00018-005-5589-y Cellular and Molecular Life Sciences © Birkhäuser Verlag, Basel, 2006 Review Sialic acid-specific lectins: occurrence, specificity and function F. Lehmanna, *, E. Tiralongob and J. Tiralongoa a Institute for Glycomics, Griffith University (Gold Coast Campus), PMB 50 Gold Coast Mail Centre Australia 9726 (Australia), Fax: +61 7 5552 8098; e-mail: [email protected] b School of Pharmacy, Griffith University (Gold Coast Campus), PMB 50 Gold Coast Mail Centre Australia 9726 (Australia) Received 13 December 2005; received after revision 9 February 2006; accepted 15 February 2006 Online First 5 April 2006 Abstract. Sialic acids consist of a family of acidic nine- through specific interactions with lectins, a family of carbon sugars that are typically located at the terminal po- proteins that recognise and bind sugars. This review will sitions of a variety of glycoconjugates. Naturally occur- present a detailed overview of our current knowledge re- ring sialic acids show an immense diversity of structure, garding the occurrence, specificity and function of sialic and this reflects their involvement in a variety of biologi- acid-specific lectins, particularly those that occur in vi- cally important processes. One such process involves the ruses, bacteria and non-vertebrate eukaryotes. direct participation of sialic acids in recognition events Keywords. Sialic acid, lectin, sialoglycoconjugate, sialic acid-specific lectin, adhesin, infectious disease, immunology. Introduction [1, 2]. The largest structural variations of naturally occurring Sia are at carbon 5, which can be substituted with either an Sialic acids (Sia) are a family of nine-carbon a-keto acids acetamido, hydroxyacetamido or hydroxyl moiety to form (Fig. -
Mouse Model of GM2 Activator Deficiency Manifests Cerebellar Pathology and Motor Impairment
Proc. Natl. Acad. Sci. USA Vol. 94, pp. 8138–8143, July 1997 Medical Sciences Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment (animal modelyGM2 gangliosidosisygene targetingylysosomal storage disease) YUJING LIU*, ALEXANDER HOFFMANN†,ALEXANDER GRINBERG‡,HEINER WESTPHAL‡,MICHAEL P. MCDONALD§, KATHERINE M. MILLER§,JACQUELINE N. CRAWLEY§,KONRAD SANDHOFF†,KINUKO SUZUKI¶, AND RICHARD L. PROIA* *Section on Biochemical Genetics, Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, ‡Laboratory of Mammalian Genes and Development, National Institute of Child Health and Development, and §Section on Behavioral Neuropharmacology, Experimental Therapeutics Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892; †Institut fu¨r Oganische Chemie und Biochemie der Universita¨tBonn, Gerhard-Domagk-Strasse 1, 53121 Bonn, Germany; and ¶Department of Pathology and Laboratory Medicine, and Neuroscience Center, University of North Carolina, Chapel Hill, NC 27599 Communicated by Stuart A. Kornfeld, Washington University School of Medicine, St. Louis, MO, May 12, 1997 (received for review March 21, 1997) ABSTRACT The GM2 activator deficiency (also known as disorder, the respective genetic lesion results in impairment of the AB variant), Tay–Sachs disease, and Sandhoff disease are the the degradation of GM2 ganglioside and related substrates. major forms of the GM2 gangliosidoses, disorders caused by In humans, in vivo GM2 ganglioside degradation requires the defective degradation of GM2 ganglioside. Tay–Sachs and Sand- GM2 activator protein to form a complex with GM2 ganglioside. hoff diseases are caused by mutations in the genes (HEXA and b-Hexosaminidase A then is able to interact with the activator- HEXB) encoding the subunits of b-hexosaminidase A. -
Metabolism of Brain Glycolipid Fatty Acids '': Yasuo Kishimoto and Norman S
Metabolism of Brain Glycolipid Fatty Acids '': Yasuo Kishimoto and Norman S. Radin, Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan ABSTRACT and sulfatides contain NFA and tIFA, The metabolism of the fatty acid moieties saturated and unsaturated; the gangliosides, of brain cerebrosides, sulfatides, and however, contain only NFA in which there are gangliosides is reviewed and discussed. only traces of unsaturated acids. In the cere- The methodology involved in the isolation t)rosides and sulfatides there are two clusters of the fatty acids is described briefly. It of FA: those around 18 carbons long and those seems clear now that most of these acids around 24 carbons long. In the gangliosides are made by chain elongation of inter- there is only one cluster, centering around 18:0, mediate length fatty acids by addition of with negligible amounts of 22:0 and 24:0. acetate residues. The unsaturated acids Other points of contrast between gangliosides are made by desaturation of the inter- and the other two can be made: the former mediate length acids (palmitic, heptade- occurs primarily in brain gray matter, the canoic, stearic) followed by chain elonga- latter are primarily in white. The former tion. The hydroxy acids are made directly has glucose attached to the ceramide residue, from the corresponding nonhydroxy acids, the latter have galactose. The former has saturated, unsaturated, and odd-numbered. only traces of odd-numbered FA; the latter All the hydroxy acids undergo oxidative can contain considerable amounts of C~ and decarboxylation to yield fatty acids con- C2.~ FA. Further differences, particularly in taining one less carbon atom. -
Prospects for Using Expression Patterns of Paramyxovirus Receptors As Biomarkers for Oncolytic Virotherapy
cancers Review Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy Olga V. Matveeva 1,* and Svetlana A. Shabalina 2,* 1 Sendai Viralytics LLC, 23 Nylander Way, Acton, MA 01720, USA 2 National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA * Correspondence: [email protected] (O.V.M.); [email protected] (S.A.S.) Received: 27 October 2020; Accepted: 1 December 2020; Published: 5 December 2020 Simple Summary: Some non-pathogenic viruses that do not cause serious illness in humans can efficiently target and kill cancer cells and may be considered candidates for cancer treatment with virotherapy. However, many cancer cells are protected from viruses. An important goal of personalized cancer treatment is to identify viruses that can kill a certain type of cancer cells. To this end, researchers investigate expression patterns of cell entry receptors, which viruses use to bind to and enter host cells. We summarized and analyzed the receptor expression patterns of two paramyxoviruses: The non-pathogenic measles and the Sendai viruses. The receptors for these viruses are different and can be proteins or lipids with attached carbohydrates. This review discusses the prospects for using these paramyxovirus receptors as biomarkers for successful personalized virotherapy for certain types of cancer. Abstract: The effectiveness of oncolytic virotherapy in cancer treatment depends on several factors, including successful virus delivery to the tumor, ability of the virus to enter the target malignant cell, virus replication, and the release of progeny virions from infected cells. The multi-stage process is influenced by the efficiency with which the virus enters host cells via specific receptors. -
Liposomal Nanovaccine Containing Α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses Via CD169+ Macrophages and Cdc1
Article Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1 Joanna Grabowska 1,†, Dorian A. Stolk 1,† , Maarten K. Nijen Twilhaar 1, Martino Ambrosini 1, Gert Storm 2,3,4, Hans J. van der Vliet 5,6, Tanja D. de Gruijl 5, Yvette van Kooyk 1 and Joke M.M. den Haan 1,* 1 Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands; [email protected] (J.G.); [email protected] (D.A.S.); [email protected] (M.K.N.T.); [email protected] (M.A.); [email protected] (Y.v.K.) 2 Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, The Netherlands; [email protected] 3 Department of Biomaterials Science and Technology, University of Twente, 7500 AE Enschede, The Netherlands 4 Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore 5 Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands; [email protected] (H.J.v.d.V.); [email protected] (T.D.d.G.) 6 Lava Therapeutics, 3584 CM Utrecht, The Netherlands * Correspondence: [email protected]; Tel.: +31-20-4448080 Citation: Grabowska, J.; Stolk, D.A.; † Authors contributed equally. Nijen Twilhaar, M.K.; Ambrosini, M.; Storm, G.; van der Vliet, H.J.; Abstract: Successful anti-cancer vaccines aim to prime and reinvigorate cytotoxic T cells and should de Gruijl, T.D.; van Kooyk, Y.; therefore comprise a potent antigen and adjuvant. -
Sphingosine Kinases and Their Metabolites Modulate Endolysosomal Trafficking in Photoreceptors
JCB: Report Sphingosine kinases and their metabolites modulate endolysosomal trafficking in photoreceptors Ikuko Yonamine,1,2 Takeshi Bamba,3 Niraj K. Nirala,1,2 Nahid Jesmin,1,2 Teresa Kosakowska-Cholody,4 Kunio Nagashima,5 Eiichiro Fukusaki,3 Jairaj K. Acharya,4 and Usha Acharya1,2 1Program in Gene Function and Expression and 2Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605 3Department of Biotechnology, Graduate School of Engineering, Osaka University, Osaka 565-0871, Japan 4Laboratory of Cell and Developmental Signaling, National Cancer Institute, Frederick, MD 21702 5Electron Microscopy Facility and Image Analysis Laboratory, Science Applications International Corporation–Frederick, Frederick, MD 21702 Downloaded from http://rupress.org/jcb/article-pdf/192/4/557/1349436/jcb_201004098.pdf by guest on 29 September 2021 nternalized membrane proteins are either transported trafficking of the G protein–coupled receptor Rhodopsin to late endosomes and lysosomes for degradation or and the light-sensitive transient receptor potential (TRP) I recycled to the plasma membrane. Although proteins channel by modulating the levels of dihydrosphingosine 1 involved in trafficking and sorting have been well studied, phosphate (DHS1P) and sphingosine 1 phosphate (S1P). far less is known about the lipid molecules that regulate the An increase in DHS1P levels relative to S1P leads to the intracellular trafficking of membrane proteins. We studied enhanced lysosomal degradation of Rhodopsin and TRP the function of sphingosine kinases and their metabolites and retinal degeneration in wild-type photoreceptors. in endosomal trafficking using Drosophila melanogaster Our results suggest that sphingosine kinases and their photoreceptors as a model system. Gain- and loss-of- metabolites modulate photoreceptor homeostasis by influ- function analyses show that sphingosine kinases affect encing endolysosomal trafficking of Rhodopsin and TRP.